Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Comment by lscfaon Jun 29, 2022 12:14am
151 Views
Post# 34789480

RE:RE:Market size?

RE:RE:Market size?

Sirona's/PRC's dark spot market size no. is a gross exaggeration. The $8 billion is for all forms of treating pigment problems including chemical peels ($3.8 billion), laser, phototherapy, microdermabrasion, drugs and topicals. Use the $677 million no. for topical segment. 


https://www.medgadget.com/2020/03/pigmentation-disorders-market-to-reach-usd-10-22-billion-by-2026-growing-at-a-cagr-of-8-4-reports-and-data.html


lscfa wrote:

Market Insight Reports projects the global hyperpigmentation treatment market will accelerate at a compound annual growth rate of 8.3% to reach $677.4 million by 2027, up from $387.7 million in 2020. In the 12 months ending in June of this year, data from consumer insights firm Spate reveals that there’s an average of 272,300 monthly Google searches for “hyperpigmentation” in the United States. At the same time, the number of those searches climbed 22.4%, and there’s been a 62.1% jump in searches for “hyperpigmentation” and “Black skin.” There are 4,700 monthly searches on average for “hyperpigmentation” in tandem with brands such as The Ordinary and Mederma.
 

https://www.beautyindependent.com/dark-spots-bright-spot-beauty-industry-hyperpigmentation-skincare/
 



 

lscfa wrote:

 

Years ago market research reported the skin lightening/whitening market size was $20 billion/yr. Now reports say it is $8 billion/yr while other reports say the dark spot reducer market is $8 billion/yr. Which is it?



 






https://www.globenewswire.com/news-release/2022/04/25/2428198/0/en/Global-Skin-Lighteners-Market-to-Reach-US-11-8-Billion-by-the-Year-2026.html

https://www.businesswire.com/news/home/20180918005523/en/Pigmentation-Disorders-Treatment-The-Global-Market-is-Set-to-Reach-9.65-Billion-by-2026---ResearchAndMarkets.com


 





<< Previous
Bullboard Posts
Next >>